欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/0279/002
药品名称Daivobet
活性成分
    • betamethasone dipropionate 0.5 mg/g
    • calcipotriol hydrate 50.0 µg/g
剂型Gel
上市许可持有人LEO Pharma A/S Industriparken 55 2750 Ballerup Denmark
参考成员国 - 产品名称Denmark (DK)
Daivobet
互认成员国 - 产品名称
    • Austria (AT)
      Daivobet 50 Mikrogramm/g + 0,5 mg/g Gel
    • Poland (PL)
      Daivobet
    • Latvia (LV)
    • Lithuania (LT)
      Daivobet 50µg/0,5mg/g gelis
    • Estonia (EE)
    • Hungary (HU)
      DAIVOBET 50 mikrogramm/0,5 mg/g gél
    • Bulgaria (BG)
      Daivobet gel
    • Czechia (CZ)
      Daivobet®
    • Romania (RO)
      Daivobet® 50 micrograme/0,5 mg/g gel
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
    • Germany (DE)
      Daivobet Kopfhaut - Gel 50 Mikrogramm / g + 0,5 mg/ g
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
      Daivobet
    • Norway (NO)
    • Finland (FI)
      Daivobet
许可日期2008/08/15
最近更新日期2024/04/22
药物ATC编码
    • D05AX52 calcipotriol, combinations
申请类型
  • TypeLevel1:Line Extension
  • TypeLevel2:Initial Application
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase